News - Men's Health, Eli Lilly

Filter

Current filters:

Men's HealthEli Lilly

Popular Filters

FDA investigating risk of stroke, heart attack and death with testosterone products

FDA investigating risk of stroke, heart attack and death with testosterone products

03-02-2014

The US Food and Drug Administration said on Friday that it is investigating the risk of stroke, heart…

AbbVieActavisAndrodermAndroGelAxironEli LillyMen's HealthNorth AmericaPharmaceuticalRegulationResearchTestosteroneUSA

Actavis confirms challenge of Lilly’s Axiron patent

Actavis confirms challenge of Lilly’s Axiron patent

14-11-2013

US generics major Actavis confirms that it has filed an Abbreviated New Drug Application with the US…

ActavisAxironEli LillyGenericsLegalMen's HealthNorth AmericaPatentsRegulation

TVM Life Science Ventures invests in Ixchelsis

09-08-2013

Canada-based TVM Life Science Ventures VII has announced the fund's second investment, with Ixchelsis…

Eli LillyFinancialIX-01IxchelsisMen's HealthPfizerPharmaceuticalResearch

Lilly's ED drug Cialis meets endpoint in LUTS/BPH study

19-03-2013

US drug major Eli Lilly (NYSE: LLY) presented results yester day at the annual European Association of…

CialisEli LillyGenito-urinaryMen's HealthPharmaceuticalResearch

Study finds "Big Pharma" fails at self-policing ED drug advertising

18-02-2013

The pharmaceutical industry's efforts to self-regulate its direct-to-consumer (DTC) advertising are "an…

BayerCialisEli LillyLevitraMarkets & MarketingMen's HealthPfizerPharmaceuticalRegulationViagra

European Commission approves Lilly's Cialis for BPH

31-10-2012

The European Commission has approved US drug major Eli Lilly's (NYSE: LLY) Cialis (tadalafil), 5mg for…

CialisEli LillyEuropeMen's HealthPharmaceuticalRegulation

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top